SCHEMBL9760981

SCHEMBL9760981

Cc1oc2ccccc2c(=O)c1C(=O)O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 4/20 0.66
▸ CYP2C19 P33261 6/20 0.54
▸ EYA3 Q99504 3/20 0.54
▸ TTR P02766 3/20 0.52
▸ KDM4E B2RXH2 3/20 0.52
▸ ALDH1A1 P00352 2/20 0.52
▸ MAPT P10636 2/20 0.52
▸ HPGD P15428 2/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ GLA P06280 1/20 0.52
▸ CYP3A4 P08684 1/20 0.52
▸ PGAM1 P18669 1/20 0.52
▸ MAOA P21397 1/20 0.52
▸ CASP1 P29466 1/20 0.52
▸ CASP7 P55210 1/20 0.52
▸ HSD17B10 Q99714 1/20 0.52
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ HTT P42858 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1398779 0.87 CYP2C19 (0.63) CYP2C9CYP2C19EYA3TTRKDM4E
SCHEMBL15346066 0.86 CYP2C9 (0.66) CYP2C9CYP2C19EYA3KDM4EALDH1A1
SCHEMBL1772596 0.82 CYP2C9 (0.64) CYP2C9CYP2C19EYA3KDM4EALDH1A1
SCHEMBL11360558 0.81 KDM4E (0.53) CYP2C9TTRKDM4EALDH1A1MAPT
SCHEMBL31217554 0.80 ALDH1A1 (0.64) CYP2C9CYP2C19KDM4EALDH1A1MAPT
SCHEMBL11881228 0.79 ALDH1A1 (0.61) CYP2C9CYP2C19KDM4EALDH1A1MAPT
SCHEMBL9760347 0.79 CYP2C9 (0.68) CYP2C9CYP2C19EYA3TTRALDH1A1
SCHEMBL6527669 0.78 ALDH1A1 (0.69) CYP2C9CYP2C19TTRKDM4EALDH1A1
SCHEMBL28245008 0.77 CYP2C19 (0.79) CYP2C9CYP2C19EYA3ALDH1A1MAPT
SCHEMBL4757017 0.77 LMNA (0.61) CYP2C9KDM4EALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-3206006-A — — None — — JP disclosed
US-20170022165-A1 PQSR MODULATORS HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH (DE) 2017-01-26 — — US disclosed
JP-H03206006-A NEW PLANT GROWTH INHIBITOR DAICEL CHEM IND LTD 1991-09-09 — — JP disclosed
US-3937837-A SUBSTITUTED CHROMONE-3-CARBONITRILES, CARBOXAMIDES AND CARBOXYLIC ACIDS USEFUL FOR PREVENTING ASTHMATIC SYMPTOMS WARNER-LAMBERT COMPANY (US) 1976-02-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170022165-A1 PQSR MODULATORS QARS1, SRPRA, MRPS35 CYP2C9 2135/4885CYP2C19 1382/4885EYA3 3012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback